Skip to main content

NVO · Novo Nordisk A S · Analyst Estimates

Track NVO — free
$43.26 +0.07 (+0.15%)
Market Cap
$192.00B
Shares
4.42B

Analyst Estimates

Compare analyst forecasts for Novo Nordisk A S across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 11:13 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
DKK
Publication date not stated
22.253
23.23383
24.53
23.0755
21.85912
23.03217
21.54667
EPS
analysts
Publication date not stated
6
0
1
1
0
Revenue
DKK
Publication date not stated
272677000000
299842461290
333771717430
Revenue
analysts
Publication date not stated
27

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
DKK
Publication date not stated
16.88
21.91029
23.74
21.98929
22.01986
21.97886
21.56956
EPS
analysts
Publication date not stated
7
1
1
5
0
Revenue
DKK
Publication date not stated
286944000000
304106522550
346724635220
Revenue
analysts
Publication date not stated
27

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
DKK
Publication date not stated
4.68
5.10867
5.33
5.133
4.788
5.10867
4.76233
EPS
analysts
Publication date not stated
3
0
1
3
0
Revenue
DKK
Publication date not stated
70680000000
72925731680
75521615000
Revenue
analysts
Publication date not stated
9

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
DKK
Publication date not stated
3.97
4.37067
5.12
4.43067
4.6695
4.37067
4.58
EPS
analysts
Publication date not stated
3
2
1
1
0
Revenue
DKK
Publication date not stated
71860231370
73995743290
75992841000
Revenue
analysts
Publication date not stated
8
Key facts CIK 353278 CUSIP 670100205 13F (30d) 32 filings 27 filers Visit website Investor relations